Evaluation of unstimulated whole saliva flow rate and stimulated parotid flow as confirmatory tests for xerostomia.

Department of Internal Medicine, School of Medicine, University of Ioannina, Greece.
Clinical and experimental rheumatology (Impact Factor: 2.97). 01/1989; 7(2):127-9.
Source: PubMed

ABSTRACT Unstimulated whole saliva collection (U.W.S.C.) and stimulated parotid flow rate (S.P.F.R.) are routine tests for evaluation of xerostomia. Different groups of investigators, however, use different normal values; some prefer one test (either one) more than the other. This prompted us to evaluate these tests in 81 well documented primary Sjögren's syndrome (prim. SS) patients and 188 age and sex matched normal volunteers. The U.W.S.C. as well as the S.P.F.R. were performed for 5 min. Lemon juice was used for stimulation and the saliva from the parotid gland was collected using modified Carlson-Crittenden cups. Normal individuals produced from between 0.20 and 6.81 ml/5 min (x +/- SD: 2.03 +/- 1.36 ml) of U.W.S. and from between 0.00 and 7.50 ml/5 min (x +/- SD: 1.00 +/- 1.10 ml) of S.P.F. No statistical differences were observed between the two salivary flow rates. Primary Sjögren's syndrome patients produced from 0.04 to 2.00 ml/5 min (x +/- SD: 0.47 +/- 0.50 ml) of U.W.S. and from 0.00 to 2.00 ml/5 min (x +/- SD: 0.37 +/- 0.56 ml) of S.P.F. Using the 95% confidence limit of the flow rates (U.W.S.: 1.25 ml/5 min and S.F.P.: 1.5 ml/5 min) observed in prim. SS patients, it was observed that 57% of the U.W.S. and 78% of the S.P.F values produced from normal individuals fall into that range. Based on these findings we conclude that these two tests are not useful for the evaluation of xerostomia.

  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE: Clinimetric tools are useful in both clinical practice and research of Sjögren's syndrome. These instruments assist in the establishment of diagnosis and in the evaluation of disease status. We reviewed the available methods used to monitor sicca signs and symptoms, fatigue, quality of life as well as activity/chronicity in SS. METHODS: PubMed and MEDLINE database were searched for the keywords "keratoconjunctivitis sicca diagnosis", "dry eye and dry mouth assessment", "sialometry", "sialochemistry", "Sjögren's syndrome outcomes", "Sjögren's syndrome activity", "Sjögren's syndrome damage", "fatigue scales in Sjögren's syndrome", and "Sjögren's syndrome quality of life". All relevant articles and pertinent secondary references were reviewed. RESULTS: As there is a moderate correlation between sicca symptoms and signs, the assessment of both is crucial. Most of the tests focus on oral and ocular dryness (vital dye staining, tear quantification, tear composition, sialometry, sialochemistry, etc.) and may not be disease specific. Symptoms such as dryness and fatigue have been evaluated with different instruments, being the PROFAD and ESSPRI disease-specific tools. Standardized measures for activity (SSDAI, SCAI, and ESSDAI) and chronicity (SSDDI and SSDI) indexes are currently used, however these methods still present limitations such as low external validity and cross-validation. CONCLUSION: The heterogeneous nature of the disease and its slow progression, challenge the evaluation of these patients. The use of composite measures might increase our ability to diagnose and evaluate disease activity and cumulative irreversible organ injury in this disease. However the distinction among oral and ocular activity vs. damage is still a matter of research.
    Seminars in arthritis and rheumatism 01/2013; 42(6). DOI:10.1016/j.semarthrit.2012.09.008 · 3.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective In our current work in vivo examination of AQP5 distribution in labial salivary glands following stimulation of secretion has been done in normal individuals andin Sjögren's syndrome patients.Subjects and Methods For this study, we selected 5 patients with primary Sjögren's syndrome (mean age 62,4 + 10,6 SD years) diagnosed in accordance with the European Cooperative Community classification criteria. There were 5 patients (mean age 27 + 2,5 SD years) in the control group. The subcellular distribution of AQP5 in human labial gland biopsies was determined with light and immunoelectron microscopy before and 30 min after administration of oral pilocarpine.ResultsIn unstimulated control and Sjögren's labial glands AQP5 is about 90% localized in the apical plasma membrane, with only rarely associated gold particles with intracellular membrane structures. We have found no evidence of pilocarpine-induced changes in localization of AQP5 in either healthy individuals or Sjögren's patients.Conclusions Our studies indicate that neither Sjögren's syndrome itself, nor muscarinic cholinergic stimulation in vivo caused any significant changes in the distribution of AQP5 in the labial salivary gland cells.This article is protected by copyright. All rights reserved.
    Oral Diseases 03/2014; DOI:10.1111/odi.12239 · 2.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The goal of this article is to review existing research on the prevalence and etiology of dry mouth in the vulnerable elders and identify knowledge gaps. Vulnerable elders (VE) are persons aged >65 years who have any or all of the following: limited mobility, limited resources, or complex health status. A systematic search was conducted of PubMed sources from 1989 to May 2010. Evidence was evaluated on the prevalence and etiology of xerostomia and salivary gland hypofunction (SGH) in VE. The search identified 1,422 publications. The inclusion/exclusion criteria yielded 348 articles, 80 of which are cited herein. Research has showed a high prevalence of xerostomia and SGH in VE. Common etiologies include medications, poor general health, female gender, and age. Gaps still exist in the evaluation of dry mouth in VE. Nonetheless, oral dryness will remain an important health issue as life expectancy increases.
    07/2012; 114(1):52-60. DOI:10.1016/j.oooo.2011.11.014